Last reviewed · How we verify
NCT06134505
Evaluation of the Efficiency of Local Application of Bee Products in the Care of Diaper Dermatitis in Infants
NA trial testing Use of Barrier cream group 1 in the healing of diaper dermatitis in Diaper Dermatitis Healing in 93 participants. Completed in 8 November 2023.
8 November 2023
Quick facts
| Lead sponsor | Karadeniz Technical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 93 |
| Start date | 24 December 2022 |
| Primary completion | 8 November 2023 |
| Estimated completion | 8 November 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Use of Barrier cream group 1 in the healing of diaper dermatitis
- Use of Barrier cream 2 in the healing of diaper dermatitis
- Use of olive oil in the healing of diaper dermatitis
Conditions studied
- Diaper Dermatitis Healing — all drugs for Diaper Dermatitis Healing →
Sponsor
Karadeniz Technical University
Who can join
Adults 1 Month to 6 Months, any sex, with Diaper Dermatitis Healing. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study was to evaluate the local application of bee products in the care of diaper dermatitis in infants. 1. H1: Barrier cream 1, consisting of a mixture of propolis, beeswax, queen bee larva and plants oil used in the care of diaper dermatitis, is more effective in recovering diaper dermatitis than barrier cream 2 containing zinc oxide. 2. H2: Barrier cream 1, consisting of a mixture of propolis, beeswax, queen bee larva and plants oil used in the care of diaper dermatitis, is more effective in recovering diaper dermatitis than olive oil. 3. H3: Diaper Dermatitis Severity Assessment Scale scores are lower in babies who use barrier cream 1, which consists of a mixture of propolis, beeswax, queen bee larva and plants oil, in the care of diaper dermatitis, compared to babies who use barrier cream 2, which contains zinc oxide. 4. H4: Diaper Dermatitis Severity Assessment Scale scores are lower in babies who use barrier cream 1, which consists of a mixture of propolis, beeswax, queen bee larva and plants oil, in the care of diaper dermatitis, than babies who use olive oil.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06134505
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Karadeniz Technical University trials
Trials by the same sponsor.
- NCT07526779 — Motivational Interviewing on Loneliness Level, Activities of Daily Living, and Quality of Life in Elderly · NA · not yet recruiting
- NCT07448168 — Effect of Standardized Patient Simulation on Nursing Students' Assessment, Diagnosis Skills, and Experiences · NA · not yet recruiting
- NCT07435233 — Different Reality Simulation Education Methods on Nursing Students · NA · active not recruiting
- NCT07238348 — Analgesic Effectiveness of SPSIPB Versus Thoracic Epidural and Systemic Opioid Analgesia After VATS (SPSIPB-VATS) · not yet recruiting
- NCT07297498 — The Effect of Simulation-based Education Within the Framework of the Clinical Judgment Model on Nursing Students' Clinic · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06134505 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karadeniz Technical University
- Last refreshed: 17 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06134505.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing